LunaVax

One year ago, LunaVax began with a simple question.
Today, we’re laying the foundation for a new vaccine access system in Nigeria.

Read our one-year reflection and what comes next:
https://lunavax.com/lunavax-insights-one-year-later/

Access shouldn’t depend on needles or distance.
Access is delivery.

Together we vaccinate. Together we thrive.

Luna360 Engagement Guide 2025 | LunaVax Explore the Luna360 Engagement Guide and learn how you can help drive equitable vaccine access across Africa through advocacy, partnerships, and innovation.

Fact, Fiction, or Future?
Swipe to see what’s fact — and how Microneedle Vaccine Patches (MAPs) could reshape vaccine delivery across Africa.

LunaVax is leading Africa’s first MAP + biometrics pilot in Nigeria.
Join the movement.

Nigeria has launched Africa’s largest vaccination campaign, aiming to protect nearly 100 million children with life-saving vaccines and treatments. A historic effort and a major step toward stronger immunization systems nationwide.

Read more in our News & Insights: https://lunavax.com/lunavax-insights-nigeria-leads-africas-largest-vaccination-campaign/

Thanks to National Primary Health Care Development Agency and Federal Ministry of Health Nigeria for leading this national effort.

Nigeria’s 3-Phase MAP Vaccine Roadmap (2025–2030):
A Scalable Model for Equitable Vaccine Access and Local Production

LunaVax is leading Africa’s first pilot combining microneedle vaccine patches (MAPs) with biometric verification, pioneering a new model for vaccine delivery.

Explore the full roadmap: https://lunavax.com/resources-nigeria-map-roadmap-2025-2030/

Nigeria 3-Phase MAP Vaccine Roadmap (2025–2030) Download LunaVax and Harvard GCSRT’s roadmap for Nigeria’s first MAP vaccine pilot, integrating biometrics, innovation, and local production.

Countdown to Impact:
The LunaVax MAP pilot, as part of the Harvard Medical School GCSRT program, has entered the preparatory phase for Nigeria’s first multi-state microneedle vaccine pilot.

Advancing local innovation and equitable vaccine access.

At ’s Health Without Borders convening, leaders highlighted an urgent reality: by 2030, the world could face a shortage of 11 million health workers.

A strong health workforce is also the backbone of immunization. LunaVax is committed to advancing innovations that support health workers and contribute to a more self-reliant vaccine future for Africa.

At The Tipping Point: A New Era for Global Health Leadership during , hosted by Global Health Corps and The Access Challenge, we joined Africa CDCAfrican Union, PATH, and global partners to reimagine the future of health in Africa.

LunaVax is proud to be part of this movement advancing vaccine equity and health self-reliance across the continent.

Biometrics that count.
With Simprints and Ghana Health Service, frontline teams are ensuring vaccines reach the child they are meant for. No one missed and no dose wasted. Supported by Arm, Gavi, the Vaccine Alliance, and the Steele Foundation for Hope, Simprints have a goal to reach 500,000 children by the end of 2026.

Read more in our News & Insights: https://lunavax.com/lunavax-insights-biometrics-for-vaccine-equity-in-ghana/